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Objective: The study assessed mid-term outcome of emergency endovascular repair for acute infrarenal abdominal aortic
aneurysms, with special attention to secondary interventions.
Methods: Between May 1998 and August 2005, 56 patients underwent emergent endovascular repair for a ruptured
abdominal aortic aneurysm (n  34) or an acute nonruptured abdominal aortic aneurysm (n  22). During the same
period, 322 consecutive patients underwent elective endovascular aneurysm repair and were used as control group. Five
types of stent grafts were used: Vanguard, Talent, Excluder, Zenith, and Quantum. Follow-up included abdominal
radiograph, duplex ultrasound scanning, and computed tomographic angiography. Outcome measures included all-cause
and aneurysm-related mortality, complications, and secondary interventions.
Results: Mortality at 30 days was 18%, 5%, and 1% in the ruptured, acute nonruptured, and elective aneurysm groups,
respectively. Overall mean follow-up was 38  26 months. In the ruptured aneurysm group, survival was 67.8%  8.6%
at 1 year and 62.1%  9.5% at 2 and 3 years. Seven secondary interventions (4 early and 3 late) were required in five
patients (15%), with a cumulative risk of 9.2%  5.1% at 1 year and 16.2%  8.2% at 2 and 3 years. In the acute
nonruptured aneurysm group, survival was 90.9%  6.1% at 1 year, 84.8%  8.2% at 2 years, and 76.4%  10.9% at
3 years. Four secondary interventions (1 early and 3 late) were required in four patients (18%), with a cumulative risk of
9.6%  6.5% at 1 and 2 years and 20.9%  12.0% at 3 years. In the elective aneurysm (control) group, survival was
95.2%  1.2% at 1 year, 89.9%  1.8% at 2 years, and 86.2%  2.1% at 3 years. A total of 51 secondary interventions
(4 early, 47 late) were required in 38 patients (12%), with a cumulative risk of 4.2%  1.1% at 1 year, 7.6%  1.6% at 2
years, and 12.9%  2.2% at 3 years.
Conclusions:To our surprise, emergency endovascular aneurysm repair did not present with higher secondary intervention
rate at mid-term follow-up. (J Vasc Surg 2006;44:1156-61.)More than 10 years ago, the first case report about
emergent endovascular aneurysm repair (eEVAR) was pub-
lished by Yusuf, et al.1 Since then, the feasibility of this
technique has been demonstrated by several cohort stud-
ies.2-9 These reports show 30-day mortality rates, albeit in
preselected patients, of 9% to 45%.10 They do compare well
with mortality rates of open repair for acute abdominal
aortic aneurysms (AAAs). Ameta-analysis of open repair for
ruptured AAAs (rAAAs) calculated a mortality rate of
48%.11 A review of open repair for acute nonruptured AAAs
(nrAAAs) reported a mortality rate of 15.8%.12 However,
there are no level I or II data that support the results of the
eEVAR cohort studies. One randomized controlled trial
comparing eEVAR with open repair for rAAAs is still
recruiting patients.13
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1156In view of the still poor results of open surgery, some
authors do believe that eEVAR will likely become the gold
standard for the treatment of suitable patients with
rAAAs.14 Critics argue that patient selection plays an overly
important role to be able to compare both techniques.
They also mention the risk of complications and secondary
interventions after elective EVAR.15-16 With eEVAR, an
even higher secondary intervention rate might be expected.
This could be explained in several ways:
1. Acute AAAs represent end-stage disease and are there-
fore associated with more difficult anatomy. This may
result in lower suitability and, because of angulation, in
more difficult access and deployment of the graft. This
additional technical challenge could lead to less-than-
optimal positioning and subsequent results.
2. The emergent character of the whole procedure renders
measurement and execution more tedious.
3. The presence of type II endoleaks in rAAAs could lead
to prolonged bleeding with development of abdominal
compartment syndrome, a factor that negatively affects
survival.17
A recently published article by Hechelhammer, et al18
demonstrated an increased cumulative secondary interven-
tion risk in eEVAR compared with a large elective EVAR
series from the literature. This study assessed outcome of
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referral center. It was anticipated that eEVAR would be
associated with higher incidence of complications and,
hence, of both early and late secondary interventions, com-
pared with elective EVAR.
PATIENTS AND METHODS
Patients. Between May 1998 and August 2005, 56
patients underwent eEVAR for an acute infrarenal AAA, of
whom 34 had a rAAA (61%) and 22 an acute nrAAA (39%).
From the beginning of the study period on, patients pre-
senting with an acute AAA were evaluated for eEVAR.
Prerequisites for evaluation were the availability of an en-
dovascular team and a sufficient stock of devices. From
2003 on, eEVAR was performed on an intention-to-treat
basis. Indeed, with increasing experience, an on-call team
could be provided at all times, and from then on devices
were always available.
Interpretation of hemodynamic stability in rAAA to
allow evaluation for eEVAR was left to the discretion of the
attending surgeon. Systolic blood pressures as low as 50 to
70 mm Hg were accepted in applying the “hypotensive
hemostasis” principle.19 This means that fluid administra-
tion was restricted to avoid rise in blood pressure with the
risk of subsequent bleeding.
Anatomic suitability for eEVAR was determined by
computed tomographic angiography (CTA) according to
guidelines for elective EVAR. These included a proximal
neck length 15 mm with 60° angulation and access
vessels large enough to accommodate the introducer
sheaths.20 With time patients with more peculiar anatomy
were also accepted, including those with severe angulations
Table I. Patient and aneurysm related characteristics and
rAAA
Age (year) 73  9
Male/female (%) 91/9
Aneurysm diameter (mm) 74  19
Prox. neck length (mm) 22  6
Anesthesia (%)
Local 80
General 20
Spinal 0
ASA classification 21(%)
2 0
3 32
4 68
Comorbidity (%)
Coronary artery disease 44.1
Congestive heart failure 11.8
Arrhythmia 17.6
COPD 26.5
Diabetes mellitus 11.8
Hypertension 29.4
Chronic renal failure* 11.8
rAAA, Ruptured abdominal aortic aneurysm; nrAAA, nonruptured abdom
obstructive pulmonary disease.
*Serum creatinine, 150 umol/L.of neck and iliac arteries. This decision was reached be-tween the attending vascular surgeon and interventional
radiologist.
As a frame of reference for outcome, we defined a
case-matched cohort of the 322 patients who underwent
elective endovascular AAA repairs during the study period.
During the same period, 211 patients underwent acute
open repair, of whom 161 (76%) had a rAAA and 50 (24%)
an acute nrAAA. Only 6% of patients presenting to our
hospital with an acute AAA were not treated, mainly because
of old age and comorbidity. Patient and aneurysm character-
istics and type of anesthesia used are listed in Table I. 21
Procedure. The first choice for anesthesia was local.7A
bifurcated device was used whenever possible, which rep-
resents the most physiologic solution and is our daily
practice in elective EVAR. Several types of stent grafts were
inserted. In the beginning the choice was determined by
market availability (Table II); now we have a full stock of
both Zenith (Cook, Bloomington, Ind) and Excluder
(W.L. Gore & Associates, Flagstaff, Ariz) stent grafts,
which explains their use in acute cases in our hospital.
Follow-up. Duplex ultrasound scanning (DUS) and
plain radiographs of the abdomen in four directions were
performed at discharge, 6 months, 1 year, and then yearly.
CTA was performed 4 weeks after the procedure to
confirm exclusion of the aneurysm. Thereafter CTA was
only done if routine follow-up DUS or radiographs sug-
gested any problem, including a type I or III endoleak, a
type II endoleak with increase of the aneurysmal sac diam-
eter, or in the event of migration, severe kinking, or struc-
tural damage of the stent graft. Indications for secondary
intervention included type I and III endoleak or migration
with imminent type I or III endoleak. Aneurysmal sac
of anesthesia used
Acute nrAAA Elective AAA
73  9 71  8
91/9 94/6
64  11 59  10
30  16 28  11
86 74
14 14
0 12
9 24
68 72
23 4
45.5 46.6
13.6 7.8
13.6 13.4
18.2 25.5
9.1 9.3
40.9 51.9
4.5 6.2
ortic aneurysm; ASA, American Society of Anesthesiology; COPD, chronictype
inal agrowth, with or without type II endoleak (endotension),
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cation was balanced with the patient’s age and comorbidity.
Limb occlusion with disabling claudication or critical isch-
emia or severe kinking with imminent limb occlusion was
also an indication for secondary intervention.
Definitions. An acute AAA was defined as any AAA
requiring treatment24 hours. A differentiation was made
between the rAAA and the acute nrAAA. The rAAA classi-
fication was only awarded in the presence of a retroperito-
neal hematoma on CTA. All other acute AAAs were classi-
fied as acute nrAAAs as determined by acute onset of
abdominal or back pain combined with pain at aneurysm
palpation.
Aneurysm-related deaths were defined as all deaths due
to aneurysm rupture after a primary or secondary interven-
tion or open conversion.22 Early deaths (30 days after the
primary intervention or within the same hospital admis-
sion) were all classified as aneurysm related. Late deaths
were only classified as unrelated if a nonrelated cause of
death could be attributed.
In the context of this study, complications other than
death of the patient refer only to those related to the
aneurysm or stent graft.
A secondary intervention was defined as any subse-
quent endovascular or open surgical treatment related to
aneurysm repair or complications thereof. An open conver-
sion was defined as a laparotomy with removal of the stent
graft and insertion of a surgical prosthesis. The term lapa-
rotomy implied nonconversion laparotomy only.
Statistics. Datawere prospectively collected in anAccess
database (Microsoft Corp, Redmond Wash) and analyzed
using SPSS 12.0.1 (SPSS, Chicago, Ill) and GraphPad Prism
4 (GraphPad Software, San Diego, Calif). The outcome
measures were all-cause and aneurysm-related mortality,
complications, and secondary interventions. Variables
were expressed as mean  standard deviation. Time-to-
event variables were studied with Kaplan-Meier survival
analysis. If the standard error 10%, data were not pre-
sented in the figures. Comparison of time-to-event curves
was conducted with Peto log-rank test. Values of P  .05
Table II. Stent grafts inserted
Type*
rAAA
n (%)
Acute nrAAA
n (%)
Elective AAA
n (%)
Vanguarda 0 (0) 4 (18) 27 (8)
Talentb 2 (6) 1 (5) 51 (16)
Excluderc 3 (9) 0 (0) 61 (19)
Zenithd 9 (85) 17 (77) 170 (53)
Quantume 0 (0) 0 (0) 13 (4)
rAAA, Ruptured abdominal aortic aneurysm; nrAAA, nonruptured ab-
dominal aortic aneurysm.
*The stent grafts inserted are listed in chronological order.
aBoston Scientific Corp., Waterston, Mass.
bWorld Medical/Medtronic Corp., Sunrise, Fla.
cW.L. Gore & Associates, Flagstaff, Ariz.
dCook, Bloomington, Ind.
eCordis, Miami Lakes, Fla.were considered statistically significant.RESULTS
Early complications. In the rAAA group, six (18%) of
34 patients died during the in-hospital period or30 days.
One patient died during the procedure. This 85-year-old
patient presented with an AAA extending to both iliac
bifurcations, but he died before complete exclusion. Five
patients died in the postoperative period. One patient died
the same day on the intensive care unit, probably due to a
hypovolemic shock, although the completion angiogram
showed exclusion of the AAA. Another patient died on day
4 due to cardiac failure. One patient, who underwent open
conversion because of insufficient access, died of multiple
organ failure on day 12. Another patient underwent a
secondary intervention (laparotomy) on the day of the
initial procedure for evacuation of a large retroperitoneal
hematoma and died of respiratory insufficiency on day 14.
The last patient who died had a complicated postoperative
outcome with three reinterventions (laparotomies) for
compartment syndrome, ischemic colitis, and sepsis. A
severe pneumonia developed, and he died on day 20.
Three (other) intraoperative complications occurred.
In one patient, a renal artery was inadvertently covered,
which was accepted. In another, a contralateral limb was
malpositioned. This patient also had a large retroperitoneal
hematoma; therefore a laparotomy was performed to repo-
sition the limb manually and to evacuate the hematoma. In
the third, a local arterial access problem was solved with a
patch plasty.
One (5%) of 22 patients in the acute nrAAA group died
on day 6 because of respiratory insufficiency. Another pa-
tient underwent a secondary intervention because of a
progressive groin hematoma after he had been treated with
an aortouniiliac system with a femorofemoral crossover
bypass.
In the elective AAA (control) group, the in-hospital or
30 daymortality was 3 (1%) of 322.One patient died due to
bleeding from an intracerebral metastasis and two others
due to myocardial infarction with ventricle fibrillation.
Complications requiring secondary intervention are listed
in Table III.
Late complications. Mean follow-up in the rAAA
group was 20  21 months. During that period, five
patients died after a mean of 11 months (range, 4 to 24
months). Two late deaths were due to cardiac events. One
patient died as a result of acute leukemia and another
related to an excess amount of different medications com-
bined with severe anemia, for which treatment failed. The
last late death occurred in an 86-year-old man with hypo-
volemic shock, most probably due to rupture of a concom-
itant 67-mm-diameter thoracic aortic aneurysm. Cumula-
tive survival was 67.8% 8.6% at 1 year and 62.1% 9.5%
at 2 and 3 years (Fig 1, A).
Three late complications required secondary interven-
tion. (Table III). One patient developed a proximal type I
endoleak after 4 years due to caudal migration of the graft
(Talent) that was probably caused by extension of disease.
This resulted in an overly short neck for standard EVAR,
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Finally, two patients with secondary type II endoleaks
resulting in aneurysm growth were treated. In the first, this
was done by coil-embolization after 19 months, and in the
second, by laparotomy with ligation of the inferior mesen-
teric artery and lumbar arteries after 3 months. Cumulative
secondary intervention risk (early included) was 9.2% 
5.1% at 1 year and 16.2%  8.2% at 2 and 3 years (Fig 2).
In addition to the complications requiring treatment,
three secondary type II endoleaks (1 with growth and 2
without growth) occurred. In all cases a watchful waiting
policy was adopted with a 6-month follow-up interval.
Finally, in one Excluder case, the aneurysm did grow with-
out appearance of an endoleak on DUS and CTA. This was
therefore classified as endotension, and that patient also is
on a closer follow-up regimen at 6-month intervals.
Mean follow-up was 32 25months in the acute nrAAA
Table III. Early and late secondary interventions
Secondary interventions
In ruptured AAA
Early secondary interventions
Laparotomy (4)
Late secondary interventions
Fenestrated aortic cuff (1)
Laparotomy  ligation of side branches (1)
Coil-embolization (1)
Patients without secondary interventions
Total
In acute nonruptured AAA
Early secondary interventions
Groin exploration (1)
Late secondary interventions
Wallstents  extensions (2)
Extension, custom made (1)
Patients without secondary interventions
Total
In elective AAA
Early secondary interventions
Thrombolysis Wallstent iliac limb (1)
Aortic cuff (1)
Bypass from SMA to renal artery (1)
Embolectomy Wallstent iliac limb (1)
Late secondary interventions
Embolectomy Wallstent iliac limb (2)
Embolectomy  extensions (1)
Thrombolysis Wallstent iliac limb (1)
Iliofemoral cross-over bypass (5)
PTA iliac limb (1)
PTA Wallstent iliac limb (2)
Wallstent (1)
Coil-embolization (7)
Aortic cuff (4)
Fenestrated aortic cuff (2)
Wallstents  extensions (3)
Extension, custom made (6)
Laparotomy  ligation of side branches (3)
Laparotomy  suture aneurysm sac (1)
Bridging stent graft (1)
Conversion to open repair (7)
Patients without secondary interventions
Totalgroup. During that period three patients died after a meanof 17 months (range, 6 to 31 months). Two late deaths
were due to cardiac events, and the last death was due to
cholangiocarcinoma. Cumulative survival was 90.9% 
6.1% at 1 year, 84.8% 8.2% at 2 years, and 76.4% 10.9%
at 3 years. (Fig. 1A).
Three late complications required secondary interven-
tion (Table III). In these cases, a limb extension was applied
to correct kinking and upward migration of the iliac limbs
(2 Vanguards) or an overly short initial positioning in the
common iliac artery (Talent). In both Vanguard cases,
treatment consisted of insertion of Wallstents combined
with Passager iliac extensions (Boston Scientific, Water-
town, Mass), after 35 and 38 months, respectively. In the
Talent case, a custom-made tapered iliac extension (Cook)
was inserted after 6 months. Cumulative secondary inter-
vention risk (early included) was 9.6%  6.5% at 1 and 2
years and 20.9%  12.0% at 3 years (Fig 2). There were two
N Patients %
4 2 6
3 3 9
29 85
7 34 100
1 1 4
3 3 14
18 82
4 22 100
4 4 1
47 34 11
284 88
51 322 100secondary type II endoleaks (1 each with and without
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as described earlier.
In the elective AAA (control) group, mean follow-up
was 40  25 months. During that period, 53 patients died
after a mean of 32 months (range, 2 to 84 months). Two
deaths were classified as aneurysm-related (Fig 1, B) be-
cause the cause of death was unknown, whilst there was an
endotension in one patient and a type II endoleak in the
other. Cumulative survival was 95.2%  1.2% at 1 year,
89.9%  1.8% at 2 years, and 86.2%  2.1% at 3 years
(Fig 1, A ). Complications requiring secondary interven-
Fig 1. A, Kaplan-Meier curves of patient survival expressed as all
cause mortality. B, Kaplan-Meier curves of patient survival ex-
pressed as aneurysm-related mortality. rAAA, Ruptured abdomi-
nal aortic aneurysm; nrAAA, nonruptured abdominal aortic aneu-
rysm.tion are listed in Table III. Cumulative secondary inter-vention risk (early included) was 4.2%  1.1% at 1 year,
7.6%  1.6% at 2 years, and 12.9%  2.2% at 3 years (Fig 2).
The 30-day mortality for patients who underwent open
repair for an acute infrarenal AAA was 32% in the rAAA
group and 8% in the acute nrAAA group.
DISCUSSION
In this study comparing mid-term results of emergency
EVAR in 56 patients (34 rAAA and 22 acute nrAAA) with
elective EVAR in 322 patients, survival curves differed
significantly for the rAAA and elective AAA patients. How-
ever, all cause mortality was similar between the three
cohorts when the 30-day deaths were excluded. In addi-
tion, no late aneurysm related deaths occurred in the rAAA
or the acute nrAAA groups.
Compared with elective EVAR, eEVAR in proven rup-
tures carries additional risks for early complications: in two
patients early secondary interventions were needed due to a
progressing retroperitoneal hematoma and complications
thereof.
Only one other study, by Hechelhammer, et al,18 ad-
dressed mid-term outcome of eEVAR. In that report of 37
patients with an acute rAAA, overall survival was 89% at 1
year, 84% at 2 years, and 70% at 4 years. In contrast to their
lower mortality compared with the result in this study,
there was a higher secondary aneurysm-related procedure
risk of 35% at 2 years and 44% at 3 years. These figures were
explained by a high rate of early postoperative interven-
tions. In their view, this could be a consequence of subop-
timal fluoroscopy in the emergency operating room, or
retroperitoneal hematoma. But also lack of the best-fitting
stent graft available off the shelf and the fact that many of
the interventions were performed outside office hours
Fig 2. Kaplan-Meier curves of secondary intervention risk. rAAA,
Ruptured abdominal aortic aneurysm; nrAAA, nonruptured abdom-
inal aortic aneurysm.could have played a role.
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life-threatening situation to a controlled situation that re-
sults in good survival at mid-term follow-up, and they
accept subsequent procedures to prevent rupture. Some
have even suggested that eEVAR for rAAA is a “bridge
procedure” that will ultimately allow safer, elective open
AAA repair and that it does not have to be a durable
procedure. Our results indicate, however, that eEVARmay
be a more durable procedure than expected. This is illus-
trated by the absence of a significant difference of cumula-
tive secondary intervention risk for both the rAAA and the
acute nrAAA groups compared with the control group.
Furthermore, no late conversions occurred in either the
rAAA or acute nrAAA groups.
Limitations are inherent to this type of study. First, pro-
spectively gathered data did not include information regard-
ing neck and iliac angulation for all patients, so the adverse
anatomic conditions per study group could not be presented
completely. Second, selection bias might have artificially im-
proved results to a certain extent. Before 2003, without the
availability of an endovascular team and a sufficient stock of
devices at all times, patients were not always evaluated. This
resulted in so-called black-out dates and a low inclusion. From
2003 on, with an endovascular intension-to-treat policy, 32%
of all patients were treated by endovascular means, mostly
determined by anatomic criteria only. Third, the stent grafts
that were used for each group differed to a certain extent.
Another issue is that only aneurysm-related or device-related
complicationswere analyzed. Furthermore, the indications for
secondary intervention in cases of aneurysmal sac growth due
to type II endoleak or endotension varied depending age and
comorbidity.
In conclusion, eEVAR appears to be not only lifesav-
ing but also durable in the mid-term and should there-
fore be considered in all suitable patients with acute
aneurysms.
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abdominal aortic aneurysm; nrAAA, nonruptured AAA.
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0.39 31   
0.46 30   
0.69 29   
1.2   318
1.9   317
2.2   316
2.6   315
3.75 28   
4.4                314l
5.3   313
5.69 27   
5.9   312
6.08  21  
6.31 26   
6.35 25   
6.38 24   
6.4   309
6.41  20  
6.6   307
6.71  19  
6.74 23   
7   306
7.1   305
7.13 22   
7.17 21   
7.2   304
7.4   303
7.69 20   
7.8   301
8.1   300
8.3   299
8.5   296
8.52 19   
8.7   295
9.1   293
9.3   291
9.5   290
10.1   288
10.4   287
10.6   284
10.7   282
10.9   281
11   280
11.08 18   
11.2   279
11.4   277
11.7   276
11.84  18  
12   275
12.1   274
12.3  17  
12.33 17   
12.5   272
12.6   270
12.79 16   
13.05  16  
13.3   268
Numbers at risk 
Data 
set-A 
Data set-
B
Data set-
C13.4   267
13.5   266
13.6   265
13.7   264
13.9   262
14.1   259
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14.3   257
14.56 14   
14.8   255
15   254
15.1   252
15.5   251
16.2   248
16.4   247
16.67  15  
16.7   246
16.9   245
17.1   244
17.4   243
17.9   241
18.1   239
18.3   238
19   235
19.1   234
19.23 13   
19.3  14  
19.8   233
20.2   230
20.8   227
21.1   225
21.4   223
21.6   222
21.8   219
22.3   218
22.8   217
23.3   216
23.51  13  
23.6   215
23.7 12  213
24.26  12  
24.4   212
24.46 11   
25.2   211
25.6   210
25.9   209
26.2   208
26.27  11  
26.3   207
26.4   206
26.8   205
26.9   204
27.1   203
27.4   201
27.5   200
27.6   199
27.8   198
28.1   197
29   195
29.1   193
Numbers at risk 
Data 
set-A 
Data set-
B
Data set-
C29.6   192
30.2   191
30.54  10  
31   189
31.07 10   
32.12  9  
32.15 9   
32.3   188
32.4   187
32.5   185
32.8   184
33   183
33.14 8   
33.2   182
33.3   180
33.6   179
33.9   177
34.2   176
34.8   175
35.8   173
35.93  8  
36.3   170
36.4   169
37.2   168
37.4   167
37.7   164
37.8   161
37.9   160
38.1   159
38.2   157
38.4   155
38.79  7  
40   152
40.1   150
40.2   148
40.3   147
40.6   146
40.8   144
41.4   142
41.6   141
41.69 7   
42.1   140
42.7   138
42.87 6   
43.2   137
43.9   136
44.2   134
44.7   133
44.9   132
45.1   131
45.7   129
46.8   127
47.2   125
47.3   123
Numbers at risk 
Data 
set-A 
Data set-
B
Data set-
C
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47.51 5   
47.9   121
48.4   119
48.6   117
48.8   116
49   114
49.5   113
50.1   111
50.2   109
50.5   108
50.7   107
50.93  6  
51.4   106
52.3   104
52.5   102
52.9   100
53.2   99
53.82 4   
54   98
55 3   
55.1   97
55.6   96
55.9   95
56.5   93
57   92
57.7   91
58   90
58.2   89
58.5   88
58.6   87
58.9   86
59.2   85
59.21  5  
59.3   84
60.2   83
60.46 2   
60.6   82
60.7   81
61   79
61.6   78
61.8   77
62.1   75
62.2   73
63.2   72
63.6   71
64.7   67
64.9   66
65.59  4  
65.62  3  
66.8   65
66.9   64
67.6   63
68.4   62
Numbers at risk 
Data 
set-A 
Data set-
B
Data set-
C68.6   61
68.7   60
69.2   59
69.9   58
70.1   57
70.3   54
70.6   53
71   52
71.4   50
71.7   48
72   47
73.7   46
73.8   44
74.7   43
74.8   42
75.2   40
75.3   39
75.4   38
76   37
76.2   35
76.4   33
76.7   32
76.8   31
77.1   30
77.7   29
79.36 1   
79.7   28
82.1   27
82.2   23
82.4   22
83.3   20
83.5   19
84  2  
84.5   18
84.89  1  
85   17
85.4   16
85.5   15
85.6   14
86.1   13
86.8   11
87.5   10
87.7   9
88.9   8
89.3   6
89.7   5
90.2   4
90.7   3
93.9   2
94.2   1
Numbers at risk 
Data 
set-A 
Data set-
B
Data set-
C
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A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
0 100  100  100  
0.01 94.11765 4.035261   99.68944 0.310076 
0.1     99.37791 0.438514 
0.13 91.17647 4.864331     
0.2   95.45454 4.440948 99.06638 0.536505 
0.39 88.23529 5.525508     
0.46 85.29412 6.073872     
0.69 82.35294 6.53787     
1.2     99.06638  
1.9     98.75387 0.619177 
2.2     98.44136 0.691601 
2.6     98.12885 0.756726 
3.75 79.41177 6.934458     
4.4     97.81633 0.8163 
5.3     97.50382 0.871462 
5.69 79.41177      
5.9     97.19131 0.923004 
6.08   90.90909 6.12909   
6.31 79.41177      
6.35 79.41177      
6.38 79.41177      
6.4     97.19131  
6.41   90.90909    
6.6     97.19131  
6.71   90.90909    
6.74 79.41177      
7     97.19131  
7.1     96.87265 0.973432 
7.13 79.41177      
7.17 75.63025 7.565379     
7.2     96.87265  
7.4     96.87265  
7.69 71.84874 8.07709     
7.8     96.55081 1.022017 
8.1     96.55081  
8.3     96.55081  
8.5     96.55081  
8.52 71.84874      
8.7     96.55081  
9.1     96.55081  
9.3     96.55081  
9.5     96.55081  
10.1     96.55081  
10.4     96.55081  
10.6     96.21085 1.073475 
10.7     95.86967 1.122576 
10.9     95.5285 1.169276 
11     95.5285  
11.08 67.85714 8.558015     
Survival proportions 
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11.4     95.5285  
11.7     95.18238 1.215188 
11.84   90.90909    
12     95.18238  
12.1     95.18238  
12.3   90.90909    
12.33 67.85714      
12.5     94.48251 1.303132 
12.6     94.48251  
12.79 67.85714      
13.05   90.90909    
13.3     94.12997 1.345114 
13.4     94.12997  
13.5     94.12997  
13.6     93.77476 1.386145 
13.7     93.77476  
13.9     93.77476  
14.1     93.77476  
14.17 67.85714      
14.3     93.40987 1.427969 
14.56 67.85714      
14.8     93.40987  
15     93.40987  
15.1     93.40987  
15.5     93.40987  
16.2     93.03322 1.471047 
16.4     93.03322  
16.67   84.84849 8.185728   
16.7     93.03322  
16.9     92.6535 1.513259 
17.1     92.27377 1.55397 
17.4     92.27377  
17.9     91.50801 1.632688 
18.1     91.50801  
18.3     91.50801  
19     91.11861 1.671531 
19.1     91.11861  
19.23 67.85714      
19.3   84.84849    
19.8     91.11861  
20.2     91.11861  
20.8     91.11861  
21.1     91.11861  
21.4     90.71001 1.713249 
21.6     90.71001  
21.8     90.71001  
22.3     90.71001  
22.8     90.71001  
23.3     90.29005 1.756033 
23.51   84.84849    
23.6     89.8701 1.797379 
23.7 62.20238 9.531697   89.8701  
24.26   84.84849    
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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24.46 62.20238      
25.2     89.8701  
25.6     89.8701  
25.9     89.8701  
26.2     89.8701  
26.27   84.84849    
26.3     89.43594 1.840385 
26.4     89.00179 1.881964 
26.8     89.00179  
26.9     89.00179  
27.1     89.00179  
27.4     88.559 1.923987 
27.5     88.1162 1.96466 
27.6     88.1162  
27.8     88.1162  
28.1     88.1162  
29     88.1162  
29.1     87.65964 2.006828 
29.6     87.65964  
30.2     87.65964  
30.54   76.36364 10.91185   
31     87.65964  
31.07 62.20238      
32.12   76.36364    
32.15 62.20238      
32.3     87.65964  
32.4     87.65964  
32.5     87.18581 2.051157 
32.8     86.71197 2.094025 
33     86.71197  
33.14 62.20238      
33.2     86.71197  
33.3     86.23024 2.137084 
33.6     86.23024  
33.9     86.23024  
34.2     86.23024  
34.8     86.23024  
35.8     86.23024  
35.93   76.36364    
36.3     86.23024  
36.4     86.23024  
37.2     86.23024  
37.4     86.23024  
37.7     86.23024  
37.8     86.23024  
37.9     86.23024  
38.1     85.6879 2.191377 
38.2     85.6879  
38.4     85.6879  
38.79   76.36364    
40     85.6879  
40.1     85.6879  
40.2     85.6879  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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40.6     85.6879  
40.8     85.6879  
41.4     85.6879  
41.6     85.6879  
41.69 62.20238      
42.1     85.07585 2.259583 
42.7     85.07585  
42.87 62.20238      
43.2     85.07585  
43.9     85.07585  
44.2     85.07585  
44.7     85.07585  
44.9     85.07585  
45.1     85.07585  
45.7     85.07585  
46.8     84.40596 2.338983 
47.2     84.40596  
47.3     83.71973 2.418538 
47.5     83.71973  
47.51 62.20238      
47.9     83.71973  
48.4     83.71973  
48.6     83.71973  
48.8     83.71973  
49     83.71973  
49.5     83.71973  
50.1     82.9655 2.511603 
50.2     82.9655  
50.5     82.9655  
50.7     82.19012 2.605069 
50.93   76.36364    
51.4     82.19012  
52.3     82.19012  
52.5     82.19012  
52.9     82.19012  
53.2     82.19012  
53.82 62.20238      
54     82.19012  
55 62.20238      
55.1     82.19012  
55.6     82.19012  
55.9     82.19012  
56.5     81.30636 2.722842 
57     80.42259 2.833041 
57.7     80.42259  
58     79.52901 2.939111 
58.2     79.52901  
58.5     79.52901  
58.6     79.52901  
58.9     79.52901  
59.2     79.52901  
59.21   76.36364    
59.3     79.52901  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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60.46 62.20238      
60.6     79.52901  
60.7     79.52901  
61     78.52232 3.069475 
61.6     78.52232  
61.8     78.52232  
62.1     78.52232  
62.2     78.52232  
63.2     78.52232  
63.6     78.52232  
64.7     78.52232  
64.9     77.33258 3.245358 
65.59   76.36364    
65.62   76.36364    
66.8     77.33258  
66.9     77.33258  
67.6     77.33258  
68.4     77.33258  
68.6     77.33258  
68.7     76.04371 3.43769 
69.2     76.04371  
69.9     74.7326 3.619815 
70.1     73.42151 3.786312 
70.3     73.42151  
70.6     73.42151  
71     73.42151  
71.4     73.42151  
71.7     73.42151  
72     71.85935 4.015099 
73.7     71.85935  
73.8     71.85935  
74.7     71.85935  
74.8     71.85935  
75.2     70.06287 4.297873 
75.3     68.26638 4.547658 
75.4     68.26638  
76     66.42134 4.784408 
76.2     66.42134  
76.4     66.42134  
76.7     66.42134  
76.8     66.42134  
77.1     66.42134  
77.7     66.42134  
79.36 62.20238      
79.7     66.42134  
82.1     66.42134  
82.2     66.42134  
82.4     66.42134  
83.3     66.42134  
83.5     62.92548 5.66765 
84   76.36364    
84.5     62.92548  
84.89   76.36364    
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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85.4     62.92548  
85.5     62.92548  
85.6     62.92548  
86.1     62.92548  
86.8     62.92548  
87.5     62.92548  
87.7     62.92548  
88.9     62.92548  
89.3     62.92548  
89.7     62.92548  
90.2     62.92548  
90.7     62.92548  
93.9     62.92548  
94.2     62.92548  
Comparison of Survival Curves: A with C (rAAA with elective AAA)  
Logrank Test  
  Chi square 16.79 
  df 1 
  P value P<0.0001 
  P value summary *** 
  Are the survival curves sig different? Yes 
Median survival  
Data 1:Data Set-A Undefined 
Data 1:Data set-C Undefined 
Hazard Ratio  
  Ratio 3.520 
  95% CI of ratio 3.234 to 27.85 
Comparison of Survival Curves: B with C (acute nrAAA with elective AAA)  
Logrank Test  
  Chi square 0.2049 
  df 1 
  P value 0.6508 
  P value summary ns 
  Are the survival curves sig different? No 
Median survival  
Data 1:Data Set-B Undefined 
Data 1:Data set-C Undefined 
Hazard Ratio  
  Ratio 1.263 
  95% CI of ratio 0.4208 to 3.996 
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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Volume 44, Number 6 Oranen et al 1161.e10Comparison of Survival Curves: A with B (rAAA with acute nrAAA)  
Logrank Test  
  Chi square 1.973 
  df 1 
  P value 0.1601 
  P value summary ns 
  Are the survival curves sig different? No 
Median survival  
Data 1:Data Set-A Undefined 
Data 1:Data Set-B Undefined 
Hazard Ratio  
  Ratio 2.214 
  95% CI of ratio 0.7483 to 5.794 
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Fig 1. Data presented with standard error bars. rAAA, Ruptured
abdominal aortic aneurysm; nrAAA, nonruptured AAA.
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
0 34 22 322
0.01 34  322
0.1   320
0.13 32   
0.2  22 319
0.39 31   
0.46 30   
0.69 29   
1.2   318
1.9   317
2.2   316
2.6   315
3.75 28   
4.4   314al
5.3   313
5.69 27   
5.9   312
6.08  21  
6.31 26   
6.35 25   
6.38 24   
6.4   309
6.41  20  
6.6   307
6.71  19  
6.74 23   
7   306
7.1   305
7.13 22   
7.17 21   
7.2   304
7.4   303
7.69 20   
7.8   301
8.1   300
8.3   299
8.5   296
8.52 19   
8.7   295
9.1   293
9.3   291
9.5   290
10.1   288
10.4   287
10.6   284
10.7   282
10.9   281
11   280
11.08 18   
11.2   279
11.4   277
11.7   276
11.84  18  
12   275
12.1   274
12.3  17  
12.33 17   
12.5   272
12.6   270
12.79 16   
13.05  16  
13.3   268
13.4   267
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 13.5   266
13.6   265
13.7   264
13.9   262
14.1   259
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 6 Oranen et al 1161.e1229.6   192
30.2   191
30.54  10  
31   189
31.07 10   
32.12  9  
32.15 9   
32.3   188
32.4   187
32.5   185
32.8   184
33   183
33.14 8   
33.2   182
33.3   180
33.6   179
33.9   177
34.2   176
34.8   175
35.8   173
35.93  8  
36.3   170
36.4   169
37.2   168
37.4   167
37.7   164
37.8   161
37.9   160
38.1   159
38.2   157
38.4   155
38.79  7  
40   152
40.1   150
40.2   148
40.3   147
40.6   146
40.8   144
41.4   142
41.6   141
41.69 7   
42.1   140
42.7   138
42.87 6   
43.2   137
43.9   136
44.2   134
44.7   133
44.9   132
45.1   131
45.7   129
46.8   127
47.2   125
47.3   123
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
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47.51 5   
47.9   121
48.4   119
48.6   117
48.8   116
49   114
49.5   113
50.1   111
50.2   109
50.5   108
50.7   107
50.93  6  
51.4   106
52.3   104
52.5   102
52.9   100
53.2   99
53.82 4   
54   98
55 3   
55.1   97
55.6   96
55.9   95
56.5   93
57   92
57.7   91
58   90
58.2   89
58.5   88
58.6   87
58.9   86
59.2   85
59.21  5  
59.3   84
60.2   83
60.46 2   
60.6   82
60.7   81
61   79
61.6   78
61.8   77
62.1   75
62.2   73
63.2   72
63.6   71
64.7   67
64.9   66
65.59  4  
65.62  3  
66.8   65
66.9   64
67.6   63
68.4   62
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 68.6   61
68.7   60
69.2   59
69.9   58
70.1   57
70.3   54
70.6   53
71   52
71.4   50
71.7   48
72   47
73.7   46
73.8   44
74.7   43
74.8   42
75.2   40
75.3   39
75.4   38
76   37
76.2   35
76.4   33
76.7   32
76.8   31
77.1   30
77.7   29
79.36 1   
79.7   28
82.1   27
82.2   23
82.4   22
83.3   20
83.5   19
84  2  
84.5   18
84.89  1  
85   17
85.4   16
85.5   15
85.6   14
86.1   13
86.8   11
87.5   10
87.7   9
88.9   8
89.3   6
89.7   5
90.2   4
90.7   3
93.9   2
94.2   1
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
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11.4     99.06638  
11.7     99.06638  
11.84   95.45454    
12     99.06638  
12.1     99.06638  
12.3   95.45454    
12.33 82.35294      
12.5     99.06638  
12.6     99.06638  
12.79 82.35294      
13.05   95.45454    
13.3     99.06638  
13.4     99.06638  
13.5     99.06638  
13.6     99.06638  
13.7     99.06638  
13.9     99.06638  
14.1     99.06638  
14.17 82.35294      
14.3     99.06638  
14.56 82.35294      
14.8     99.06638  
15     99.06638  
15.1     99.06638  
15.5     99.06638  
16.2     99.06638  
16.4     99.06638  
16.67   95.45454    
16.7     99.06638  
16.9     98.66203 0.669572 
17.1     98.66203  
17.4     98.66203  
17.9     98.66203  
18.1     98.66203  
18.3     98.66203  
19     98.66203  
19.1     98.66203  
19.23 82.35294      
19.3   95.45454    
19.8     98.66203  
20.2     98.66203  
20.8     98.66203  
21.1     98.66203  
21.4     98.66203  
21.6     98.66203  
21.8     98.66203  
22.3     98.66203  
22.8     98.66203  
23.3     98.66203  
23.51   95.45454    
23.6     98.66203  
23.7 82.35294    98.66203  
24.26   95.45454    
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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24.46 82.35294      
25.2     98.66203  
25.6     98.66203  
25.9     98.66203  
26.2     98.66203  
26.27   95.45454    
26.3     98.66203  
26.4     98.66203  
26.8     98.66203  
26.9     98.66203  
27.1     98.66203  
27.4     98.66203  
27.5     98.66203  
27.6     98.66203  
27.8     98.66203  
28.1     98.66203  
29     98.66203  
29.1     98.66203  
29.6     98.66203  
30.2     98.66203  
30.54   95.45454    
31     98.66203  
31.07 82.35294      
32.12   95.45454    
32.15 82.35294      
32.3     98.66203  
32.4     98.66203  
32.5     98.66203  
32.8     98.66203  
33     98.66203  
33.14 82.35294      
33.2     98.66203  
33.3     98.66203  
33.6     98.66203  
33.9     98.66203  
34.2     98.66203  
34.8     98.66203  
35.8     98.66203  
35.93   95.45454    
36.3     98.66203  
36.4     98.66203  
37.2     98.66203  
37.4     98.66203  
37.7     98.66203  
37.8     98.66203  
37.9     98.66203  
38.1     98.66203  
38.2     98.66203  
38.4     98.66203  
38.79   95.45454    
40     98.66203  
40.1     98.66203  
40.2     98.66203  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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40.6     98.66203  
40.8     98.66203  
41.4     98.66203  
41.6     98.66203  
41.69 82.35294      
42.1     98.66203  
42.7     98.66203  
42.87 82.35294      
43.2     98.66203  
43.9     98.66203  
44.2     98.66203  
44.7     98.66203  
44.9     98.66203  
45.1     98.66203  
45.7     98.66203  
46.8     98.66203  
47.2     98.66203  
47.3     98.66203  
47.5     98.66203  
47.51 82.35294      
47.9     98.66203  
48.4     98.66203  
48.6     98.66203  
48.8     98.66203  
49     98.66203  
49.5     98.66203  
50.1     98.66203  
50.2     98.66203  
50.5     98.66203  
50.7     98.66203  
50.93   95.45454    
51.4     98.66203  
52.3     98.66203  
52.5     98.66203  
52.9     98.66203  
53.2     98.66203  
53.82 82.35294      
54     98.66203  
55 82.35294      
55.1     98.66203  
55.6     98.66203  
55.9     98.66203  
56.5     98.66203  
57     98.66203  
57.7     98.66203  
58     98.66203  
58.2     98.66203  
58.5     98.66203  
58.6     98.66203  
58.9     98.66203  
59.2     98.66203  
59.21   95.45454    
59.3     98.66203  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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60.46 82.35294      
60.6     98.66203  
60.7     98.66203  
61     98.66203  
61.6     98.66203  
61.8     98.66203  
62.1     98.66203  
62.2     98.66203  
63.2     98.66203  
63.6     98.66203  
64.7     98.66203  
64.9     98.66203  
65.59   95.45454    
65.62   95.45454    
66.8     98.66203  
66.9     98.66203  
67.6     98.66203  
68.4     98.66203  
68.6     98.66203  
68.7     98.66203  
69.2     98.66203  
69.9     98.66203  
70.1     98.66203  
70.3     98.66203  
70.6     98.66203  
71     98.66203  
71.4     98.66203  
71.7     98.66203  
72     98.66203  
73.7     98.66203  
73.8     98.66203  
74.7     98.66203  
74.8     98.66203  
75.2     98.66203  
75.3     96.13223 2.580968 
75.4     96.13223  
76     96.13223  
76.2     96.13223  
76.4     96.13223  
76.7     96.13223  
76.8     96.13223  
77.1     96.13223  
77.7     96.13223  
79.36 82.35294      
79.7     96.13223  
82.1     96.13223  
82.2     96.13223  
82.4     96.13223  
83.3     96.13223  
83.5     96.13223  
84   95.45454    
84.5     96.13223  
84.89   95.45454    
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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85.4     96.13223  
85.5     96.13223  
85.6     96.13223  
86.1     96.13223  
86.8     96.13223  
87.5     96.13223  
87.7     96.13223  
88.9     96.13223  
89.3     96.13223  
89.7     96.13223  
90.2     96.13223  
90.7     96.13223  
93.9     96.13223  
94.2     96.13223  
Comparison of Survival Curves: A with C (rAAA with elective AAA)  
Logrank Test  
  Chi square 32.13 
  df 1 
  P value P<0.0001 
  P value summary *** 
  Are the survival curves sig different? Yes 
Median survival  
Data 1:Data Set-A Undefined 
Data 1:Data Set-C Undefined 
Hazard Ratio  
  Ratio 13.61 
  95% CI of ratio 61.18 to 4735 
Comparison of Survival Curves: B with C (acute nrAAA with elective AAA)  
Logrank Test  
  Chi square 1.211 
  df 1 
  P value 0.2710 
  P value summary ns 
  Are the survival curves sig different? No 
Median survival  
Data 1:Data Set-B Undefined 
Data 1:Data Set-C Undefined 
Hazard Ratio  
  Ratio 3.132 
  95% CI of ratio 0.2280 to 193.4 
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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Fig 1. Data presented with standard error bars. rAAA, Ruptured
abdominal aortic aneurysm; nrAAA, nonruptured AAA.3.6   306
3.75 27   
3.8   305
4.4   304
5.3   303
5.69 26   
5.9   302
6.08  20  
6.12  19  
6.31 25   
6.35 24   
6.38 23   
6.4   299
6.41  18  
6.6   297
6.71  17  
6.74 22   
7   296
7.1   295
7.13 21   
7.17 20   
7.2   294
7.4   293
7.69 19   
7.7   291
7.8   290
8.1   289
8.3   288
8.5   285
8.52 18   
8.7   284
9.1   282
9.3   280
9.5   279
10.1   277
10.4   276
10.6   273
10.7   271
10.9   270
11   269
11.2   268
11.4   266
11.5   264
11.7   263
11.84  16  
12   262
12.1   261
12.33 17   
12.5   259
12.6   257
12.79 16   
12.9   255
13.05  15  
13.3   254
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
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13.5   252
13.6   251
13.7   250
13.9   248
14   245
14.1   244
14.17 15   
14.3   242
14.56 14   
14.8   241
14.9   239
15   238
15.1   236
15.5   235
16.2   232
16.4   231
16.7   230
16.9   229
17.1   228
17.4   227
17.9   225
18.1   223
18.3   222
18.51 13   
19   220
19.1   219
19.3  14  
19.8   218
20.2   215
20.7   212
20.8   211
21.1   209
21.3   207
21.4   206
21.6   205
21.8   203
22.3   202
22.4   201
22.8   200
23.3   199
23.51  13  
23.6   198
23.7 12  197
23.9   196
24.26  12  
24.4   195
24.46 11   
25.2   194
25.6   193
25.9   192
26   191
26.2   190
26.27  11  
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 26.3   189
26.4   188
26.8   187
26.9   186
27.1   185
27.4   182
27.5   181
27.6   180
27.8   179
28.1   178
29   176
29.1   174
29.2   173
29.6   172
29.8   171
30.2   169
30.54  10  
31   167
31.07 10   
32   166
32.12  9  
32.15 9   
32.3   165
32.4   164
32.5   162
32.8   161
33   160
33.2   159
33.3   157
33.6   156
33.9   154
34.2   153
34.52  8  
34.8   152
35.3   150
35.6   149
35.8   148
35.93  7  
36.3   145
36.4   144
37.2   143
37.4   142
37.61  6  
37.7   139
37.8   137
37.9   136
38.1   135
38.2   134
38.4   132
38.79  5  
39   129
40   128
40.1   127
40.2   126
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
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40.6   124
40.8   122
41.4   120
41.6   119
41.69 8   
42.1   118
42.7   116
42.87 7   
43.2   115
43.9   114
44.2   112
44.7   111
44.9   110
45.1   109
45.27 6   
45.7   108
46.8   106
47.2   105
47.3   104
47.5   103
47.51 5   
47.9   102
48.4   100
48.6   98
48.8   97
49   95
49.5   94
50.1   92
50.5   90
50.6   89
50.7   88
50.93  4  
51   87
51.4   86
52.3   85
52.5   83
53.2   81
53.82 4   
54   80
55 3   
55.1   79
55.6   78
55.9   77
56.2   75
56.5   74
57   73
57.7   72
58.2   71
58.5   70
58.6   69
58.9   68
59.2   67
59.21  3  
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 59.3   66
60.2   65
60.46 2   
60.6   64
60.7   63
61   61
61.6   60
61.8   59
62.1   57
62.2   56
63.2   55
63.6   54
64.7   51
64.9   50
65.59  2  
65.62  1  
66.8   49
67.6   48
68.4   47
69.2   46
69.9   45
70.1   44
70.3   41
71   40
71.4   39
71.7   37
72   36
73.7   35
73.8   33
74.8   32
75.2   30
75.4   29
76   28
76.2   27
76.4   26
76.7   25
76.8   24
77.1   23
77.7   22
79.7   21
82.1   20
82.2   16
82.4   15
83.15 1   
83.3   13
83.5   12
85.4   11
85.6   10
86.1   9
86.8   7
87.5   6
88.9   5
90.2   3
90.7   2
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
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Survival proportions (cumulative risk of secondary intervention) 
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
0 0  0  0  
0.01 5.882355 4.035261 4.545456 4.440948 0.310562 0.310076 
0.1     0.623062 0.439203 
0.13 5.882355      
0.2   4.545456  0.623062  
0.3     0.938545 0.539342 
0.39 5.882355      
0.7     1.254028 0.623099 
1.2     1.569511 0.69641 
1.4     1.884995 0.762294 
1.9     1.884995  
2.2     2.201492 0.822921 
2.6 9.243698 5.10256   2.201492  
2.9     2.520058 0.879742 
3.6     2.838615 0.932762 
3.75 9.243698      
3.8     3.157181 0.982598 
4.4     3.157181  
5.3     3.157181  
5.69 9.243698      
5.9     3.157181  
6.08   4.545456    
6.12   9.569382 6.450739   
6.31 9.243698      
6.35 9.243698      
6.38 9.243698      
6.4     3.157181  
6.41   9.569382    
6.6     3.157181  
6.71   9.569382    
6.74 9.243698      
7     3.157181  
7.1     3.157181  
7.13 9.243698      
7.17 9.243698      
7.2     3.157181  
7.4     3.157181  
7.69 9.243698      
7.7     3.489975 1.034043 
7.8     3.489975  
8.1     3.489975  
8.3     3.489975  
8.5     3.489975  
8.52 9.243698      
8.7     3.489975  
9.1     3.489975  
Numbers at risk 
Data 
set-A 
Data 
set-B 
Data 
set-C 
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9.5     3.489975  
10.1     3.489975  
10.4     3.489975  
10.6     3.489975  
10.7     3.489975  
10.9     3.489975  
11     3.489975  
11.2     3.489975  
11.4     3.852791 1.091954 
11.5     4.216988 1.146945 
11.7     4.216988  
11.84   9.569382    
12     4.216988  
12.1     4.216988  
12.33 9.243698      
12.5     4.216988  
12.6     4.216988  
12.79 9.243698      
12.9     4.592606 1.202382 
13.05   9.569382    
13.3     4.592606  
13.4     4.592606  
13.5     4.592606  
13.6     4.592606  
13.7     4.592606  
13.9     4.592606  
14     4.982025 1.258957 
14.1     4.982025  
14.17 9.243698      
14.3     4.982025  
14.56 9.243698      
14.8     5.376289 1.314019 
14.9     5.772202 1.366865 
15     5.772202  
15.1     5.772202  
15.5     5.772202  
16.2     5.772202  
16.4     5.772202  
16.7     5.772202  
16.9     5.772202  
17.1     5.772202  
17.4     5.772202  
17.9     5.772202  
18.1     5.772202  
18.3     5.772202  
18.51 16.22495 8.195942     
19     5.772202  
19.1     5.772202  
19.3   9.569382    
19.8     5.772202  
20.2     5.772202  
20.7     6.216675 1.430859 
20.8     6.216675  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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21.3     6.216675  
21.4     6.216675  
21.6     6.216675  
21.8     6.678665 1.496535 
22.3     6.678665  
22.4     7.142944 1.559448 
22.8     7.142944  
23.3     7.142944  
23.51   9.569382    
23.6     7.142944  
23.7 16.22495    7.142944  
23.9     7.616707 1.62186 
24.26   9.569382    
24.4     7.616707  
24.46 16.22495      
25.2     7.616707  
25.6     7.616707  
25.9     7.616707  
26     8.100388 1.683948 
26.2     8.100388  
26.27   9.569382    
26.3     8.100388  
26.4     8.100388  
26.8     8.100388  
26.9     8.594475 1.745875 
27.1     9.088562 1.804997 
27.4     9.088562  
27.5     9.088562  
27.6     9.088562  
27.8     9.088562  
28.1     9.088562  
29     9.605103 1.867189 
29.1     9.605103  
29.2     10.12762 1.928121 
29.6     10.12762  
29.8     11.17876 2.043815 
30.2     11.17876  
30.54   9.569382    
31     11.17876  
31.07 16.22495      
32     11.71382 2.100376 
32.12   9.569382    
32.15 16.22495      
32.3     11.71382  
32.4     11.71382  
32.5     11.71382  
32.8     11.71382  
33     11.71382  
33.2     11.71382  
33.3     11.71382  
33.6     11.71382  
33.9     11.71382  
34.2     11.71382  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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34.8     11.71382  
35.3     12.3024 2.167271 
35.6     12.89097 2.231215 
35.8     12.89097  
35.93   20.87321    
36.3     12.89097  
36.4     12.89097  
37.2     12.89097  
37.4     12.89097  
37.61   34.061 15.64283   
37.7     12.89097  
37.8     12.89097  
37.9     12.89097  
38.1     12.89097  
38.2     12.89097  
38.4     12.89097  
38.79   34.061    
39     13.56623 2.313846 
40     13.56623  
40.1     13.56623  
40.2     13.56623  
40.3     13.56623  
40.6     13.56623  
40.8     13.56623  
41.4     13.56623  
41.6     13.56623  
41.69 16.22495      
42.1     13.56623  
42.7     13.56623  
42.87 16.22495      
43.2     14.31783 2.412709 
43.9     14.31783  
44.2     14.31783  
44.7     15.08974 2.51142 
44.9     15.08974  
45.1     15.08974  
45.27 30.18746 14.46056     
45.7     15.08974  
46.8     15.08974  
47.2     15.08974  
47.3     15.08974  
47.5     15.08974  
47.51 30.18746      
47.9     15.08974  
48.4     15.08974  
48.6     15.08974  
48.8     15.08974  
49     15.08974  
49.5     15.08974  
50.1     15.08974  
50.5     15.08974  
50.6     16.04379 2.658246 
50.7     16.04379  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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51     17.0088 2.797376 
51.4     17.0088  
52.3     17.0088  
52.5     17.0088  
53.2     17.0088  
53.82 30.18746      
54     17.0088  
55 30.18746      
55.1     17.0088  
55.6     17.0088  
55.9     17.0088  
56.2     18.11536 2.970884 
56.5     18.11536  
57     18.11536  
57.7     18.11536  
58.2     18.11536  
58.5     18.11536  
58.6     18.11536  
58.9     18.11536  
59.2     18.11536  
59.21   34.061    
59.3     18.11536  
60.2     18.11536  
60.46 30.18746      
60.6     18.11536  
60.7     18.11536  
61     18.11536  
61.6     18.11536  
61.8     18.11536  
62.1     18.11536  
62.2     18.11536  
63.2     18.11536  
63.6     19.63174 3.280109 
64.7     19.63174  
64.9     19.63174  
65.59   34.061    
65.62   34.061    
66.8     19.63174  
67.6     19.63174  
68.4     19.63174  
69.2     19.63174  
69.9     19.63174  
70.1     19.63174  
70.3     19.63174  
71     19.63174  
71.4     19.63174  
71.7     19.63174  
72     19.63174  
73.7     19.63174  
73.8     19.63174  
74.8     19.63174  
75.2     19.63174  
75.4     19.63174  
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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76.2     19.63174  
76.4     19.63174  
76.7     19.63174  
76.8     19.63174  
77.1     19.63174  
77.7     19.63174  
79.7     19.63174  
82.1     19.63174  
82.2     19.63174  
82.4     19.63174  
83.15 30.18746      
83.3     19.63174  
83.5     19.63174  
85.4     19.63174  
85.6     19.63174  
86.1     19.63174  
86.8     19.63174  
87.5     19.63174  
88.9     19.63174  
90.2     19.63174  
90.7     19.63174  
93.9     19.63174  
Comparison of Survival Curves: A with C (rAAA with elective AAA)  
Logrank Test  
  Chi square 2.245 
  df 1 
  P value 0.1341 
  P value summary ns 
  Are the survival curves sig different? No 
Median survival  
Data 1:Data Set-A Undefined 
Data 1:Data Set-C Undefined 
Hazard Ratio  
  Ratio 2.007 
  95% CI of ratio 0.7453 to 9.037 
Comparison of Survival Curves: B with C (acute nrAAA with elective AAA)  
Logrank Test  
  Chi square 1.526 
  df 1 
  P value 0.2167 
  P value summary ns 
  Are the survival curves sig different? No 
Data set-
A
Data set-
A
Data set-
B
Data set-
B
Data set-
C
Data set-
C
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